Whipplewood Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7K Sell
169
-551
-77% -$64.5K 0.01% 189
2026
Q1
$86.6K Buy
720
+679
+1,656% +$78.4K 0.04% 208
2025
Q4
$4.32K Buy
+41
New +$3.85K ﹤0.01% 308
2025
Q3
Sell
-1,032
Closed -$81.7K 845
2025
Q2
$81.7K Sell
1,032
-347
-25% -$27.6K 0.04% 259
2025
Q1
$130K Sell
1,379
-201
-13% -$18.8K 0.08% 196
2024
Q4
$157K Buy
+1,580
New +$163K 0.09% 187

Other funds holding MRK

Whipplewood Advisors's MRK Position: Q2 2026 in Review

Whipplewood Advisors reduced its Merck (MRK) stake by 77% in Q2 2026, selling an estimated $64.5K and leaving 169 shares worth $21.7K. The position accounts for 0.01% of the portfolio, ranked #189.

Whipplewood Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $157K in Q4 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Whipplewood Advisors held 169 shares of Merck worth $21.7K as of Q2 2026.
  • Whipplewood Advisors sold 551 Merck shares in Q2 2026, an estimated $64.5K.
  • Merck made up 0.01% of Whipplewood Advisors's portfolio in Q2 2026, its #189 holding.
  • Whipplewood Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's Merck position peaked at $157K in Q4 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.